Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drugH.E. Nazario,Apurva A. Modi, M. Ndungu,R. Ramirez, L. Tujague, J.S. WeinsteinJOURNAL OF HEPATOLOGY(2017)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要